Catalyst Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
CPRX
CUSIP
14888U101
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 373 98.2 M $2.38 B
2024 Q4 341 97.6 M $2.04 B
2024 Q3 319 95.7 M $1.90 B
2024 Q2 282 98.4 M $1.52 B
2024 Q1 276 100 M $1.60 B
2023 Q4 266 87.8 M $1.48 B
2023 Q3 264 81.5 M $953 M
2023 Q2 260 82.4 M $1.11 B
2023 Q1 274 89.1 M $1.48 B
2022 Q4 274 92.1 M $1.71 B
2022 Q3 242 85.2 M $1.09 B
2022 Q2 196 75.8 M $532 M
2022 Q1 196 70.9 M $587 M
2021 Q4 172 66.3 M $449 M
2021 Q3 150 65.2 M $345 M
2021 Q2 146 65.5 M $377 M
2021 Q1 142 67.7 M $312 M
2020 Q4 149 68.3 M $228 M
2020 Q3 152 67.9 M $202 M
2020 Q2 147 64.7 M $299 M
2020 Q1 141 65.9 M $254 M
2019 Q4 138 64.3 M $241 M
2019 Q3 125 61.7 M $328 M
2019 Q2 114 61.8 M $237 M
2019 Q1 95 62.5 M $319 M
2018 Q4 89 50.2 M $96.4 M
2018 Q3 107 51.8 M $196 M
2018 Q2 103 54.5 M $170 M
2018 Q1 101 55.5 M $133 M
2017 Q4 108 56.1 M $219 M
2017 Q3 84 35.6 M $89.7 M
2017 Q2 73 33.9 M $93.7 M
2017 Q1 55 25.4 M $49.4 M
2016 Q4 56 23.9 M $25.0 M
2016 Q3 51 23.3 M $25.4 M
2016 Q2 63 25.4 M $18.0 M
2016 Q1 74 37.0 M $43.2 M
2015 Q4 89 42.5 M $104 M
2015 Q3 92 45.6 M $137 M
2015 Q2 90 43.5 M $180 M
2015 Q1 69 38.9 M $168 M
2014 Q4 52 27.5 M $81.3 M
2014 Q3 60 23.8 M $78.7 M
2014 Q2 53 24.8 M $62.8 M
2014 Q1 41 10.5 M $23.7 M